Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.26) per share. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year.
Crypto Hedge Funds Rise From The Ashes: 3 Industry Leaders Touting Significant Gains
The cryptocurrency hedge fund industry is witnessing a robust recovery from a challenging 2022.